Phase II clinical trial - VADS

DEBIO 1143-202
VADS
Essai clinique fermé
Public cible
Adulte
Pre-operative window-of-opportunity study of Debio 1143 with or without cisplatin in patients with resectable squamous cell carcinoma of the head and neck.
Description de l'essai

This is a trial for head and neck cancer patients who will get primary surgery. Patients receive before surgery 2 weekly injections of cisplatine in combination with an oral targeted therapy.